- Home
- PAMT vs RNAC Comparison
PAMT vs RNAC Comparison
Compare PAMT & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAMT | RNAC |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.9M | 243.0M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | PAMT | RNAC |
|---|---|---|
| Price | $13.73 | $5.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.00 | ★ $34.00 |
| AVG Volume (30 Days) | 12.5K | ★ 145.8K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | $20.12 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.15 | $5.60 |
| 52 Week High | $14.87 | $14.56 |
Technical Indicators
Market Signals| Indicator | PAMT | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 67.29 | 39.56 |
| Support Level | $9.71 | N/A |
| Resistance Level | $14.59 | $7.95 |
| Average True Range (ATR) | 1.20 | 0.74 |
| MACD | 0.09 | -0.14 |
| Stochastic Oscillator | 78.17 | 4.27 |
Price Performance
Historical ComparisonAbout PAMT PAMT CORP
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.